Literature DB >> 26769307

Current Research in Outcome Measures for Pediatric Rheumatic and Autoinflammatory Diseases.

Erkan Demirkaya1, Alessandro Consolaro2, Hafize Emine Sonmez3, Gabriella Giancane2, Dogan Simsek4, Angelo Ravelli2.   

Abstract

A rational management of children and adolescents with rheumatic and autoinflammatory diseases requires the regular assessment of the level of disease activity and of child health and well-being through the use of well-validated outcome measures. Ideally, such instruments should be simple and feasible and easily applicable in standard clinical practice. In recent years, a number of novel outcome measures have been developed and validated for use in pediatric patients with rheumatic and autoinflammatory illnesses. Furthermore, there has been an increased focus on the appraisal of child and parent perception of the disease impact. The new tools have markedly enlarged the spectrum of disorders and health domains that can be assessed in a standardized way. This progress will help to enhance the reliability of research studies and clinical trials. The aim of the present review is to provide an update of the recent advances in this field of research.

Entities:  

Keywords:  Autoinflammatory diseases; Disease activity; Disease damage; Health-related quality of life; Outcome measures; Pediatric rheumatic diseases

Mesh:

Year:  2016        PMID: 26769307     DOI: 10.1007/s11926-015-0558-4

Source DB:  PubMed          Journal:  Curr Rheumatol Rep        ISSN: 1523-3774            Impact factor:   4.592


  61 in total

Review 1.  Assessing patients with lupus: towards a drug responder index.

Authors:  D Isenberg; R Ramsey-Goldman
Journal:  Rheumatology (Oxford)       Date:  1999-11       Impact factor: 7.580

2.  Defining criteria for disease activity states in juvenile idiopathic arthritis.

Authors:  Alessandro Consolaro; Angelo Ravelli
Journal:  Rheumatology (Oxford)       Date:  2015-12-10       Impact factor: 7.580

3.  Development and initial validation of the Vasculitis Damage Index for the standardized clinical assessment of damage in the systemic vasculitides.

Authors:  A R Exley; P A Bacon; R A Luqmani; G D Kitas; C Gordon; C O Savage; D Adu
Journal:  Arthritis Rheum       Date:  1997-02

Review 4.  The pharmacologic basis of treatment with colchicine in children with familial Mediterranean fever.

Authors:  D Rigante; I La Torraca; L Avallone; A L Pugliese; S Gaspari; A Stabile
Journal:  Eur Rev Med Pharmacol Sci       Date:  2006 Jul-Aug       Impact factor: 3.507

5.  Preliminary definition of improvement in juvenile arthritis.

Authors:  E H Giannini; N Ruperto; A Ravelli; D J Lovell; D T Felson; A Martini
Journal:  Arthritis Rheum       Date:  1997-07

6.  Measurement of health status, functional status, and quality of life in children with juvenile idiopathic arthritis: clinical science for the pediatrician.

Authors:  Ciarán M Duffy
Journal:  Pediatr Clin North Am       Date:  2005-04       Impact factor: 3.278

Review 7.  Proposed preliminary core set measures for disease outcome assessment in adult and juvenile idiopathic inflammatory myopathies.

Authors:  F W Miller; L G Rider; Y L Chung; R Cooper; K Danko; V Farewell; I Lundberg; C Morrison; L Oakley; I Oakley; C Pilkington; J Vencovsky; K Vincent; D L Scott; D A Isenberg
Journal:  Rheumatology (Oxford)       Date:  2001-11       Impact factor: 7.580

8.  Development and validation of a composite disease activity score for juvenile idiopathic arthritis.

Authors:  Alessandro Consolaro; Nicolino Ruperto; Anna Bazso; Angela Pistorio; Silvia Magni-Manzoni; Giovanni Filocamo; Clara Malattia; Stefania Viola; Alberto Martini; Angelo Ravelli
Journal:  Arthritis Rheum       Date:  2009-05-15

Review 9.  The development and initial validation of the Systemic Lupus International Collaborating Clinics/American College of Rheumatology damage index for systemic lupus erythematosus.

Authors:  D Gladman; E Ginzler; C Goldsmith; P Fortin; M Liang; M Urowitz; P Bacon; S Bombardieri; J Hanly; E Hay; D Isenberg; J Jones; K Kalunian; P Maddison; O Nived; M Petri; M Richter; J Sanchez-Guerrero; M Snaith; G Sturfelt; D Symmons; A Zoma
Journal:  Arthritis Rheum       Date:  1996-03

10.  Validation of the auto-inflammatory diseases activity index (AIDAI) for hereditary recurrent fever syndromes.

Authors:  Maryam Piram; Isabelle Koné-Paut; Helen J Lachmann; Joost Frenkel; Seza Ozen; Jasmin Kuemmerle-Deschner; Silvia Stojanov; Anna Simon; Martina Finetti; Maria Pia Sormani; Alberto Martini; Marco Gattorno; Nicolino Ruperto
Journal:  Ann Rheum Dis       Date:  2013-09-11       Impact factor: 19.103

View more
  3 in total

1.  Number of Episodes Can Be Used as a Disease Activity Measure in Familial Mediterranean Fever.

Authors:  David Piskin; Zehra Serap Arici; Dilek Konukbay; Micol Romano; Balahan Makay; Nuray Ayaz; Yelda Bilginer; Roberta A Berard; Hakan Poyrazoglu; Ozgur Kasapcopur; Ronald M Laxer; Kathy Speechley; Erkan Demirkaya
Journal:  Front Pediatr       Date:  2022-04-27       Impact factor: 3.569

2.  A new biopsychosocial and clinical questionnaire to assess juvenile idiopathic arthritis: JAB-Q.

Authors:  Edibe Unal; Ezgi Deniz Batu; Hafize Emine Sonmez; Zehra Serap Arici; Gamze Arin; Nur Banu Karaca; Erdal Sag; Selcan Demir; Duygu Aydin Hakli; Aykut Ozcadirci; Fatma Birgul Oflaz; Reha Alpar; Yelda Bilginer; Seza Ozen
Journal:  Rheumatol Int       Date:  2018-06-05       Impact factor: 2.631

3.  Leflunomide treatment in juvenile idiopathic arthritis.

Authors:  Nuray Aktay Ayaz; Şerife Gül Karadağ; Figen Çakmak; Mustafa Çakan; Ayşe Tanatar; Hafize Emine Sönmez
Journal:  Rheumatol Int       Date:  2019-07-20       Impact factor: 2.631

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.